Delivery Order SPE2DB20D3103-SPE2DB23FM6C7

Award Date 3/1/23
Potential Completion Date 3/2/23
Potential Value $7.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under contract SPE2DB22D2007|SPE2DB23FJ1VV, valued at $3,789.11. The contract is for the supply of NEXIUM DR 40 MG CAPSULE 90S medical products to the Defense Logistics Agency (DLA), a defense agency. The award has an ultimate completion date of April 25, 2023 and is a firm fixed-price contract. This contract is not designated as a set-aside. Amerisourcebergen, as a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NEXIUM DR 20 MG PACKET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,046.11 Delivery Order contract has a firm fixed price and an ultimate completion date of April 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award is for the delivery of Nexium DR 40 mg capsules to the Defense Logistics Agency (DLA). The $26,029.63 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 11, 2022. The ultimate completion date for this order is May 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) as a for-profit organization....
This federal contract award is for the delivery of Nexium DR 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $3,713.99, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by parent company Cencora, Inc. The $12,126.36 firm-fixed-price delivery order is for the supply of NEXIUM DR 40 MG CAPSULE 90S, a prescription medication. The award has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NEXIUM DR 20 MG CAPSULE 90S. The $7,607.45 firm-fixed-price contract has a completion date of September 27, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Nexium DR 40 mg capsules, a brand-name pharmaceutical product, with a ceiling value of $10,220.71 and a completion date of December 5, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen Drug Corp holds a...
This federal contract award, SPE2DB22D3011|SPE2DB23FQ1CB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,107.37 firm fixed-price delivery order is for the supply of 4560986172 NEXIUM DR 40 MG CAPSULE 90S. The award has an ultimate completion date of May 19, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Nexium DR 40 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,383.23, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,197.99, is a delivery order contract for the supply of the pharmaceutical product Nexium DR 40 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of April 20, 2023. Amerisourcebergen is not a small business, and the contract does not...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM6C7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,750.62 for the delivery of Nexium 40 mg capsules. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of March 2, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA in support of military and veteran healthcare programs. This award does not have a set-aside designation, indicating it was issued through full and open competition.

Generated 2/27/25, 10:23 AM